Santen Pharmaceutical Co Ltd
OTC:SNPHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Santen Pharmaceutical Co Ltd
OTC:SNPHF
|
JP |
|
F
|
Future City Leasehold Real Estate Investment Trust
SET:FUTURERT
|
TH |
Intrinsic Value
The intrinsic value of 
Santen Pharmaceutical Co Ltd (SNPHF) under the Base Case is 14.01 USD per share.
Compared with the current market price of 13.05 USD, the stock appears
Undervalued by 7% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Santen Pharmaceutical Does
Santen Pharmaceutical is a Japan-based drug company that focuses almost entirely on eye care. It develops, manufactures, and sells prescription medicines and eye drops for conditions such as glaucoma, dry eye, allergies, infections, and other disorders of the eye. It also sells some over-the-counter eye products and related treatments in selected markets.
- Headquarters
- Japan JP
- Employees
- 3 849
- IPO date
- Nov 4, 1963
Revenue & Expenses Breakdown
Santen Pharmaceutical Co Ltd
Earnings Waterfall
Santen Pharmaceutical Co Ltd
The intrinsic value for Santen Pharmaceutical Co Ltd (SNPHF) under the Base Case is 14.01 USD.
Compared with the current market price of 13.05 USD, the stock appears Undervalued by 7% .